Currently there are at least 102 Covid-19 antibody treatments in various stages of development, according to David Thomas, vice president of Industry Research at BIO, the trade association representing the biotechnology industry. Thomas does the research that goes into his organization's Covid-19 therapeutic development tracker. He said there are so many treatments under development, it's hard to keep up.
"I never looked at it to grow this big, this fast, and I've worked on all different therapeutic areas from Alzheimer's to cancer, and to see a pipeline of this size and this breadth is amazing," Thomas said.
"I never looked at it to grow this big, this fast, and I've worked on all different therapeutic areas from Alzheimer's to cancer, and to see a pipeline of this size and this breadth is amazing," Thomas said.
No comments:
Post a Comment